Testing effectiveness (Phase 2)Study completedNCT01739218
What this trial is testing
Bevacizumab (Avastin) in Neoadjuvant Therapy in Participants With International Federation of Gynecology and Obstetrics (FIGO) Stage IIIC/IV Ovarian, Tubal, or Peritoneal Cancer, Initially Unresectable
Who this might be right for
Ovarian Cancer
Hoffmann-La Roche 99